Stroke and Bleeding Risks in Patients with Atrial Fibrillation

Area of Science:

• Cardiology
• Neurology
• Pharmacology

Background:

• Atrial fibrillation (AF) is the most prevalent cardiac arrhythmia.
• AF significantly elevates the risk of stroke, mortality, and disability.
• Patients with AF face increased bleeding risks, particularly with anticoagulant use.

Purpose of the Study:

• To review the role of atrial fibrillation as a stroke risk factor.
• To evaluate stroke prediction schemes in AF patients.
• To assess bleeding risk prediction in AF patients.

Main Methods:

• Literature review of recent research on anticoagulation and stroke prevention in AF.
• Analysis of existing stroke risk stratification tools.
• Evaluation of bleeding risk assessment strategies.

Main Results:

• Atrial fibrillation is a major independent risk factor for ischemic stroke.
• Various clinical schemes effectively predict stroke risk in AF.
• Anticoagulant therapy, while reducing stroke, increases bleeding risk, necessitating risk-benefit assessment.

Conclusions:

• Effective stroke risk stratification is crucial for managing AF patients.
• Newer anticoagulants offer alternatives to warfarin, but bleeding risk must be monitored.
• Balancing stroke prevention and bleeding risk is key in AF management.